# Mangoceuticals, Inc.: Form 8-K, filed May 23, 2025

- Company: [Mangoceuticals, Inc.](/companies/mgrx.md) (CIK 1938046)
- Form: 8-K
- Filed: 2025-05-23
- Accepted by EDGAR: May 23, 2025, 17:27 ET
- Period: 2025-05-22
- Accession: 0001641172-25-012336
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1938046/000164117225012336/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1938046/000164117225012336/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1938046/000164117225012336/form8-k.htm

Filed May 23, 2025.
Source: SEC EDGAR, the filing index for accession 0001641172-25-012336. Last ingested by Listed: Nov 6, 2026, 18:28 ET. No prices; not investment advice.